ANIP Earnings

Quarterly EPS
$-1.27
Q3 2024
$-0.55
Q4 2024
$0.70
Q1 2025
$0.37
Q2 2025
$1.19
Q3 2025
$1.23
Q4 2025
$1.31
Q1 2026
$1.09
Q2 2026
Latest Revenue266.0M
Latest Net Income24.7M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$1.09266.0M24.7M+25.9%+194.6%
Q1 2026$1.31237.5M29.5M+20.5%+87.1%
Q4 2025$1.23247.1M27.5M+29.6%+323.6%
Q3 2025$1.19227.8M26.6M+53.6%+193.7%
Q2 2025$0.37211.4M8.5M+53.1%+364.3%
Q1 2025$0.70197.1M15.7M+43.4%-16.7%
Q4 2024-$0.55190.6M-10276000+44.8%-1,475.0%
Q3 2024-$1.27148.3M-24166000+12.5%-376.1%
Q2 2024-$0.14138.0M-2287000
Q1 2024$0.84137.4M18.2M
Q4 2023$0.04131.7M1.2M
Q3 2023$0.46131.8M9.9M
ANI Pharmaceuticals (ANIP) — Earnings